{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-046489","form_type":"8-K","ticker":"BFRG","cik":"0001829247","company_name":"BullFrog AI Holdings, Inc.","filed_at":"2023-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.818601+00:00","generated_at":"2026-06-07T06:01:58.532975+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bullfrog AI highlights 2023 achievements: $8.4M IPO, first revenue, key partnerships","bullets":["Completed $8.4M IPO listing on Nasdaq in 2023; maintained low burn rate quarter to quarter.","Recorded first earned revenue in Q3 2023; transition to commercial operations.","Entered exclusive partnership with Lieber Institute for Brain Development for neuropsychiatric drug discovery.","Demonstrated efficacy of oncology drug candidates BF-223 and BF-222 in glioblastoma animal model; patent issued for BF-223.","Identified three novel colorectal cancer targets via JCVI partnership; market $11.5B in 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-046489","json":"https://secwatch.observer/filing/0001493152-23-046489.json","markdown":"https://secwatch.observer/filing/0001493152-23-046489.md","text":"https://secwatch.observer/filing/0001493152-23-046489.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829247/000149315223046489/0001493152-23-046489-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829247/000149315223046489/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T06:01:58.532975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}